Literature DB >> 17880426

The R1162 relaxase/primase contains two, type IV transport signals that require the small plasmid protein MobB.

Christopher Parker1, Richard J Meyer.   

Abstract

The relaxase of the plasmid R1162 is a large protein essential for conjugative transfer and containing two different and physically separate catalytic activities. The N-terminal half cleaves one of the DNA strands at the origin of transfer (oriT) and becomes covalently linked to the 5' terminal phosphate; the C-terminal half is a primase essential for initiation of plasmid vegetative replication. We show here that the two parts of the protein are independently transported by the type IV pathway. Part of the domain containing the catalytic activity, as well as an adjacent region, is required in each case, but the required regions do not physically overlap. Both transport systems contribute to the overall frequency of conjugative transfer. MobB is a small protein, encoded within mobA but in a different reading frame, that stabilizes the relaxase at oriT. MobB is required for efficient type IV transport of both the complete relaxase and its two, separate functional halves. MobB inserts into the membrane and could thus stabilize the association between the relaxase and the type IV transfer apparatus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880426     DOI: 10.1111/j.1365-2958.2007.05925.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  26 in total

1.  Single-stranded DNA binding by F TraI relaxase and helicase domains is coordinately regulated.

Authors:  Lubomír Dostál; Joel F Schildbach
Journal:  J Bacteriol       Date:  2010-04-30       Impact factor: 3.490

2.  Chimeric Coupling Proteins Mediate Transfer of Heterologous Type IV Effectors through the Escherichia coli pKM101-Encoded Conjugation Machine.

Authors:  Neal Whitaker; Trista M Berry; Nathan Rosenthal; Jay E Gordon; Christian Gonzalez-Rivera; Kathy B Sheehan; Hilary K Truchan; Lauren VieBrock; Irene L G Newton; Jason A Carlyon; Peter J Christie
Journal:  J Bacteriol       Date:  2016-09-09       Impact factor: 3.490

Review 3.  Mechanism and structure of the bacterial type IV secretion systems.

Authors:  Peter J Christie; Neal Whitaker; Christian González-Rivera
Journal:  Biochim Biophys Acta       Date:  2014-01-02

4.  The All-Alpha Domains of Coupling Proteins from the Agrobacterium tumefaciens VirB/VirD4 and Enterococcus faecalis pCF10-Encoded Type IV Secretion Systems Confer Specificity to Binding of Cognate DNA Substrates.

Authors:  Neal Whitaker; Yuqing Chen; Simon J Jakubowski; Mayukh K Sarkar; Feng Li; Peter J Christie
Journal:  J Bacteriol       Date:  2015-05-04       Impact factor: 3.490

Review 5.  Biological diversity of prokaryotic type IV secretion systems.

Authors:  Cristina E Alvarez-Martinez; Peter J Christie
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

6.  Functional organization of MobB, a small protein required for efficient conjugal transfer of plasmid R1162.

Authors:  Richard Meyer
Journal:  J Bacteriol       Date:  2011-05-27       Impact factor: 3.490

Review 7.  The Mosaic Type IV Secretion Systems.

Authors:  Peter J Christie
Journal:  EcoSal Plus       Date:  2016-10

8.  DNA substrate-induced activation of the Agrobacterium VirB/VirD4 type IV secretion system.

Authors:  Eric Cascales; Krishnamohan Atmakuri; Mayukh K Sarkar; Peter J Christie
Journal:  J Bacteriol       Date:  2013-04-05       Impact factor: 3.490

9.  Mapping Type IV Secretion Signals on the Primase Encoded by the Broad-Host-Range Plasmid R1162 (RSF1010).

Authors:  Richard Meyer
Journal:  J Bacteriol       Date:  2015-08-03       Impact factor: 3.490

10.  Plasmid r1 conjugative DNA processing is regulated at the coupling protein interface.

Authors:  Sanja Mihajlovic; Silvia Lang; Marta V Sut; Heimo Strohmaier; Christian J Gruber; Günther Koraimann; Elena Cabezón; Gabriel Moncalián; Fernando de la Cruz; Ellen L Zechner
Journal:  J Bacteriol       Date:  2009-09-18       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.